| Ytd | 115.61% | |
| 1y | 115.61% |
| Open | 36.00 | Prev Close | 36.00 | Low | 35.20 | High | 36.75 | Mkt Cap | 3.47B |
| Vol | 167.06K | Avg Vol | 1.19M | EPS | -1.67 | P/E | N/A | Forward P/E | 13.68 |
| Beta | N/A | Short Ratio | 0.72 | Inst. Own | 52.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 30.30 | 200-d Avg | 20.24 | 1yr Est | 34.88 |
LIFE News
Not for distribution to United States newswire services or for dissemination in the United States VA
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2026) - Getty Copper Inc. (TSXV: GTC) (
On September 16, 2026, Ethos Technologies Inc. (the "Company" or "Ethos") addressed
U.S. stock futures rose, but Beta Bionics fell 7.1% after pricing a stock offering; several other st
Austin Hankwtiz is joined by Peter Collis, co-founder and CEO of Ethos Technologies, to discuss how
Three financial stocks are showing overbought signals, indicating short-term downside potential for
Citigroup analyst Ronald Josey maintains Ethos Technologies (NASDAQ:LIFE) with a Buy and raises t
Citizens analyst Matthew J. Carletti maintains Ethos Technologies (NASDAQ:LIFE) with a Market Out
Ethos Technologies Inc (NASDAQ: LIFE) reported strong Q2 results, beating earnings and sales estimat
Baird analyst Colin Sebastian maintains Ethos Technologies (NASDAQ:LIFE) with a Outperform and ra
Barclays analyst Ross Sandler maintains Ethos Technologies (NASDAQ:LIFE) with a Overweight and ra
Palantir Technologies Inc (PLTR) shares jumped 16.1% in pre-market trading on upbeat Q2 results, wit
Ethos Technologies (NASDAQ:LIFE) raises FY2026 sales outlook from $561.000 million-$565.000 million
Ethos Technologies (NASDAQ:LIFE) sees Q3 sales of $160.000 million-$164.000 million vs $119.982 mill
Ethos (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access
Ethos Technologies (NASDAQ:LIFE) reported quarterly earnings of $0.53 per share which beat the analy
U.S. stock futures mixed, Dow futures up 0.2%. Noble Corp. (NE) down in pre-market on worse-than-exp
JP Morgan analyst Pablo Singzon maintains Ethos Technologies (NASDAQ:LIFE) with a Overweight and
Shares of Ethos Technologies Inc (NASDAQ: LIFE) are trading sharply lower on Thursday after short-se
https://thebearcave.substack.com/p/problems-at-ethos-technologies-life
U.S. stock futures rise on Dow gaining 200 points. Doximity (DOCS) shares drop 21.3% after reporting
Ethos (NASDAQ:LIFE), a leading life insurance technology company on a mission to democratize access
Barclays analyst Ross Sandler maintains Ethos Technologies (NASDAQ:LIFE) with a Overweight and ra
Citizens analyst Matthew J. Carletti maintains Ethos Technologies (NASDAQ:LIFE) with a Market Out
U.S. stocks were mixed, Nasdaq up 150 points. Albemarle (ALB) rose 9.8% on strong earnings and raise
Ethos Technologies (NASDAQ:LIFE) raises FY2026 sales outlook from $510.000 million-$514.000 million
Ethos Technologies (NASDAQ:LIFE) sees Q2 sales of $114.000 million-$118.000 million vs $114.091 mill
Ethos Technologies (NASDAQ:LIFE) reported quarterly earnings of $0.38 per share which beat the analy
Ethos Technologies Inc. (NASDAQ:LIFE), a leading life insurance technology company on a mission to d
Citigroup analyst Ronald Josey maintains Ethos Technologies (NASDAQ:LIFE) with a Buy and raises t
Ethos Technologies (NASDAQ:LIFE) sees FY2026 sales of $510.000 million-$514.000 million vs $508.354
Ethos Technologies (NASDAQ:LIFE) sees Q1 sales of $144.000 million-$146.000 million vs $108.323 mill
Ethos Technologies (NASDAQ:LIFE) reported quarterly earnings of $0.42 per share which beat the analy
Deutsche Bank analyst Lee Horowitz initiates coverage on Ethos Technologies (NASDAQ:LIFE) with a
William Blair analyst Adam Klauber initiates coverage on Ethos Technologies (NASDAQ:LIFE) with a
Citigroup analyst Ronald Josey initiates coverage on Ethos Technologies (NASDAQ:LIFE) with a Buy
JP Morgan analyst Pablo Singzon initiates coverage on Ethos Technologies (NASDAQ:LIFE) with a Ove
Barclays analyst Ross Sandler initiates coverage on Ethos Technologies (NASDAQ:LIFE) with a Overw
B of A Securities analyst Michael McGovern initiates coverage on Ethos Technologies (NASDAQ:LIFE)
Citizens analyst Matthew Carletti initiates coverage on Ethos Technologies (NASDAQ:LIFE) with a M
Goldman Sachs analyst Eric Sheridan initiates coverage on Ethos Technologies (NASDAQ:LIFE) with a
Baird analyst Colin Sebastian initiates coverage on Ethos Technologies (NASDAQ:LIFE) with a Outpe
aTyr Pharma, Inc. (NASDAQ:LIFE) ("aTyr" or the "Company"), a clinical stage biotechn
HC Wainwright & Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:LIFE) with a Buy
HC Wainwright & Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:LIFE) with a Buy